The FDA has revoked the emergency use authorization status of monoclonal antibody treatments, causing centers nationwide to shut down.

The announcement Monday evening was made without notice, leaving centers no time to properly shut down or cancel the scheduled appointments of their patients.

The FDA has stated their decision is based on the treatments "unlikely to be active against the Omicron variant." This leaves Pfizer and Merck pills as the primary authorized therapeutics.